EoE is a chronic inflammatory disease characterized by the accumulation of a certain type of white blood cell (called an eosinophil) in the esophagus, which can lead to dysphagia (difficulty swallowing).

How do I talk to my doctor about EoE?

Your doctor is the best source of information about EoE and the symptoms you may be experiencing. You can use this helpful Doctor Discussion Guide to get that conversation started.

EOHILIA is the first and only 12-week, FDA-approved oral treatment designed for people with EoE 11 years and older. EOHILIA is intended to provide relief* from EoE inflammation. EOHILIA has not been shown to be safe and effective for longer than 12 weeks.

What should I know before taking EOHILIA?

Make sure to see the detailed Instructions for Use that comes with EOHILIA for information about how to prepare and take it and how to properly store and throw away (dispose of) used EOHILIA stick packs.Take EOHILIA exactly as your healthcare provider tells you:EOHILIA is taken by mouth 2 times a day. (An easy schedule to remember and stick to is “Once in the morning. Once in the evening.”) Do not mix EOHILIA with food or liquid. Avoid drinking grapefruit juice during treatment with EOHILIA. Do not eat or drink at the same time as taking EOHILIA. Wait until at least 30 minutes to eat or drink after taking EOHILIA. Do not change your dose or stop taking EOHILIA unless your healthcare provider tells you.

How should I store EOHILIA?

The EOHILIA on-the-go stick packs do not need to be refrigerated. So treatment is always ready to go. EOHILIA should be stored at controlled room temperature between 36°F to 77°F (2°C to 25°C). Do NOT freeze.

EOHILIA helps to address inflammation in the esophagus. EOHILIA is a liquid-like form of budesonide (a corticosteroid) specifically formulated to treat inflammation in the esophagus. While the exact way corticosteroids work on EoE inflammation is not known, EOHILIA works on a wide range of inflammatory cells.

How long does it take for EOHILIA to start working?

While results may vary, the majority of people who took EOHILIA in clinical studies had fewer dysphagia symptoms and inflammation related to EoE after 12 weeks. Learn more about the clinical study results for EOHILIA here.

What are the side effects of EOHILIA?

The safety of EOHILIA was established in a 12-week clinical study of 318 adult and adolescent patients 11 years of age and older with EoE. The most common side effects of EOHILIA include: respiratory tract infection; sore throat; fungal infections of the mouth, throat, and esophagus (thrush); adrenal suppression; headache; and acid-related damage to the esophagus lining (erosive infection of the stomach and intestine [gastroenteritis]). These are not all the possible side effects of EOHILIA. Safety results were similar in a second, smaller study of 92 patients. EOHILIA may cause serious side effects, including hypercorticism (effects of having too much corticosteroid medicine in your blood), adrenal suppression (a condition in which the adrenal glands do not make enough steroid hormones), immunosuppression (decreased ability of your body to fight infections) and increased risk of infection, erosive esophagitis (acid-related damage to the esophagus lining), effect on growth, worsening of allergies, and Kaposi’s sarcoma. Be sure to talk to your or your child’s doctor about any side effects that are bothersome or do not go away. Make sure to ask your doctor about potential side effects. It’s an important part of the conversation, and it’s important for you to understand both the benefits and the risks of treatment. For additional information, please see Important Safety Information and Patient Information and talk to your doctor.

Who shouldn’t take EOHILIA?

Do not take EOHILIA if you are allergic to budesonide or any of the ingredients in EOHILIA. Please click for Patient Information and Instructions for Use.

Waiting on a prescription?

EOHILIA, like many other prescription medications, will likely need approval by your health insurance company for it to be covered. The doctor’s office typically takes 1-2 weeks to complete this process. Stay in touch with your doctor’s office or pharmacist while they work through insurance coverage for EOHILIA. For more information about the prescription process, download the EOHILIA Copay FAQ Guide.

Does EOHILIA have a copay program?

Yes, the EOHILIA Patient Support and Copay Program provides financial support for commercially insured patients who qualify for the program. Patients are not eligible if they are beneficiaries of, or any part of the prescription is covered by, a government-funded healthcare program. For additional eligibility and restrictions, click here.

What is the EOHILIA Patient Support and Copay Program?

The EOHILIA Patient Support and Copay Program is here to help guide you along your EoE treatment journey. By joining it, you’ll receive educational email content to help you have informed discussions with your doctor. Patients can also sign up to receive a copay card to bring to their pharmacy to start on EOHILIA for as little as $0.† Want to learn more about the EOHILIA Patient Support and Copay Program? Click here.

A neon sign saying - Turn the tables on EoE.

EOHILIA. Designed for EoE.
Dedicated to relief.^*

Evidence-based guidelines from the American College of Gastroenterology (ACG) on diagnosis and management of EoE have given EOHILIA, as part of a group of drugs, a strong recommendation as a first-line treatment option for EoE. This is based on a moderate level of clinical trial data using GRADE methodology.*

The best source of information is your healthcare provider if you want to learn more about the guidelines and EOHILIA.

*GRADE is a formal process used to evaluate how strong the evidence is and how confident healthcare providers can be in recommending a medication for use in clinical care.

What is EOHILIA?

It is the first and only 12-week, FDA-approved oral treatment for EoE in people 11 years and older.

Learn more

EOHILIA (budesonide oral suspension) box and premixed packet

Why EOHILIA?

EOHILIA has been proven to treat EoE inflammation in the esophagus, as demonstrated in two clinical trials.†

See clinical results

†In two clinical trials, EOHILIA showed a decrease in eosinophils (a type of white blood cell) in the esophagus and improvement in dysphagia (difficulty swallowing).

The EOHILIA Patient Support and Copay Program

The EOHILIA Patient Support and Copay Program is designed to support eligible commercially insured patients on their treatment journey. Sign up below to receive a digital copay card and updates about EOHILIA delivered straight to your inbox.

Eligible commercial patients may qualify for Head Start, providing EOHILIA at no cost (for up to 3 months or until coverage is approved).

Read the EOHILIA Terms and Conditions here.